Literature DB >> 11053101

Jaks and stats as therapeutic targets.

J J O'Shea1, R Visconti, T P Cheng, M Gadina.   

Abstract

Cytokines have critical functions in regulating immune responses. A large number of these factors bind related receptors termed the Type I and Type II families of cytokine receptors. These receptors activate Janus kinases (Jaks) and Stat family of transcription factors. The essential and specific function of Jaks and Stats is particularly well illustrated by human and mouse mutations. The possibility that these molecules could be targeted to produce novel immunosuppressive compounds is considered in this review.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11053101      PMCID: PMC1766632          DOI: 10.1136/ard.59.suppl_1.i115

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  59 in total

1.  Regulation of the Jak2 tyrosine kinase by its pseudokinase domain.

Authors:  P Saharinen; K Takaluoma; O Silvennoinen
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

Review 2.  Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia.

Authors:  B J Druker; N B Lydon
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

3.  Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.

Authors:  V Lacronique; A Boureux; R Monni; S Dumon; M Mauchauffé; P Mayeux; F Gouilleux; R Berger; S Gisselbrecht; J Ghysdael; O A Bernard
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

4.  Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression.

Authors:  G B Udy; R P Towers; R G Snell; R J Wilkins; S H Park; P A Ram; D J Waxman; H W Davey
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

5.  A specific inhibitor of janus kinase-3 increases survival in a transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  V N Trieu; R Liu; X P Liu; F M Uckun
Journal:  Biochem Biophys Res Commun       Date:  2000-01-07       Impact factor: 3.575

6.  In vivo toxicity and pharmacokinetic features of the janus kinase 3 inhibitor WHI-P131 [4-(4'hydroxyphenyl)-amino-6,7- dimethoxyquinazoline.

Authors:  F M Uckun; O Ek; X P Liu; C L Chen
Journal:  Clin Cancer Res       Date:  1999-10       Impact factor: 12.531

Review 7.  Signaling through the hematopoietic cytokine receptors.

Authors:  J N Ihle; B A Witthuhn; F W Quelle; K Yamamoto; O Silvennoinen
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

Review 8.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

9.  Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains.

Authors:  M Chen; A Cheng; F Candotti; Y J Zhou; A Hymel; A Fasth; L D Notarangelo; J J O'Shea
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

10.  Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice.

Authors:  M K Kennedy; M Glaccum; S N Brown; E A Butz; J L Viney; M Embers; N Matsuki; K Charrier; L Sedger; C R Willis; K Brasel; P J Morrissey; K Stocking; J C Schuh; S Joyce; J J Peschon
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

View more
  4 in total

Review 1.  B cells: new ways to inhibit their function in rheumatoid arthritis.

Authors:  Robert H Carter
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

2.  Expression of Jak3, STAT1, STAT4, and STAT6 in inflammatory arthritis: unique Jak3 and STAT4 expression in dendritic cells in seropositive rheumatoid arthritis.

Authors:  J G Walker; M J Ahern; M Coleman; H Weedon; V Papangelis; D Beroukas; P J Roberts-Thomson; M D Smith
Journal:  Ann Rheum Dis       Date:  2005-08-11       Impact factor: 19.103

3.  Medical immunology: a new journal for a new subspecialty.

Authors:  Kendall A Smith
Journal:  Med Immunol       Date:  2002-09-30

Review 4.  The Role of Structure in the Biology of Interferon Signaling.

Authors:  Mark R Walter
Journal:  Front Immunol       Date:  2020-11-12       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.